Role and mechanism(s) of incretin-dependent therapies for treating diabetes mellitus
Food and Drug Administration (FDA) approved semaglutide (Wegovy) for chronic weight management in adults with obesity or overweight individuals who have at least one weight-related health condition, such as hypertension, type 2 diabetes, or high cholesterol
To learn more about your options, take our free online weight loss assessment
Recognizing these challenges is part of PlexusDx's empathetic approach at PlexusDx
The study involved more than 4,200 adults from diverse populations across six continents, including hunter-gatherers, pastoralists, farmers, and those living in industrialized countries
And it doesn't mean something is wrong